|

货币单位:美元(USD)

Xenetic Biosciences, Inc. (xbio)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

James F. Parslow	James F. Parslow is currently a Director at Lipoxen Technologies Ltd., a Director at Xenetic Biosciences (UK) Ltd., and the Chief Executive & Financial Officer at Xenetic Biosciences, Inc. He previously worked as the Chief Financial Officer & Treasurer at Spire Corp., Vice President-Finance & Administration at Thermo Power Corp., Senior Financial Officer at Thermo Ecotek Corp., Controller at Costar Technologies, Inc., and Chief Financial Officer, Secretary & Treasurer at World Energy Solutions, Inc. (Massachusetts). Mr. Parslow received his undergraduate degree from the College of the Holy Cross (Massachusetts) and holds an MBA from Bentley University.
Adam E. Logal	Adam E. Logal is currently the Chairman at Xenetic Biosciences, Inc. since 2017. He is also currently serving as the Director at Bio-Reference Laboratories, Inc. since 2015, the Director at OPKO Biologics Ltd. since 2014, and the CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. since 2007. Formerly, Mr. Logal served as the Finance Director, Secretary, Treasurer & CAO at eXegenics, Inc. in 2007. He was also a Director at SciVac Therapeutics, Inc. Additionally, he held the position of Independent Director at VBI Vaccines, Inc. from 2015 to 2018. Prior to that, he was the Chief Financial & Accounting Officer at Nabi Biopharmaceuticals from 2002 to 2007. Lastly, he served as the President at GeneDx LLC in 2020 and 2021.

James F. Parslow

James F. Parslow is currently a Director at Lipoxen Technologies Ltd., a Director at Xenetic Biosciences (UK) Ltd., and the Chief Executive & Financial Officer at Xenetic Biosciences, Inc. He previously worked as the Chief Financial Officer & Treasurer at Spire Corp., Vice President-Finance & Administration at Thermo Power Corp., Senior Financial Officer at Thermo Ecotek Corp., Controller at Costar Technologies, Inc., and Chief Financial Officer, Secretary & Treasurer at World Energy Solutions, Inc. (Massachusetts). Mr. Parslow received his undergraduate degree from the College of the Holy Cross (Massachusetts) and holds an MBA from Bentley University.

Adam E. Logal

Adam E. Logal is currently the Chairman at Xenetic Biosciences, Inc. since 2017. He is also currently serving as the Director at Bio-Reference Laboratories, Inc. since 2015, the Director at OPKO Biologics Ltd. since 2014, and the CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. since 2007. Formerly, Mr. Logal served as the Finance Director, Secretary, Treasurer & CAO at eXegenics, Inc. in 2007. He was also a Director at SciVac Therapeutics, Inc. Additionally, he held the position of Independent Director at VBI Vaccines, Inc. from 2015 to 2018. Prior to that, he was the Chief Financial & Accounting Officer at Nabi Biopharmaceuticals from 2002 to 2007. Lastly, he served as the President at GeneDx LLC in 2020 and 2021.